 |
 |

Nasopharyngectomy After Failure of 2 Courses of Radiation Therapy
Hani Z. Ibrahim, MD;
Melinda S. Moir, MD;
Willard W. Fee, MD
Arch Otolaryngol Head Neck Surg. 2002;128:1196-1197.
ABSTRACT
 |  |
Background Recurrence of nasopharyngeal carcinoma after initial therapy has been
reported to range between 18% and 54%. As an alternative to surgical salvage,
patients with recurrent nasopharyngeal carcinoma are offered a second course
of radiation therapy. If this second course fails, patients may be candidates
for surgical resection.
Objective To identify the effectiveness and morbidity of surgical resection of
recurrent nasopharyngeal carcinoma in patients who have received 2 cycles
of external beam radiation.
Design and Setting Retrospective survey of 6 patients in a university-based practice who
underwent resection of recurrent nasopharyngeal carcinoma after 2 courses
of radiation therapy.
Patients Our study group comprised 4 women and 2 men aged between 35 and 67 years.
All patients underwent 2 courses of radiation with a mean total dose of 11 500
rad (115 Gy) (range, 9500-13 200 rad [95-132 Gy]) delivered to the nasopharynx
prior to resection. The mean duration between the second course of radiation
and resection is 21 months (range, 8-52 months). The mean follow-up period
is 7.2 years (range, 4.2-11.5 years).
Intervention Nasopharyngectomy after failure of 2 courses of radiation therapy.
Main Outcome Measures Postoperative clinical outcome and morbidity.
Results Five years after resection, 1 patient died of disease. The remaining
5 patients (83%) are alive with no evidence of disease. Osteomyelitis is the
most common complication, affecting 5 patients. Three of the 5 patients with
osteomyelitis required operative debridement of the nasopharynx and split-thickness
skin grafting. Other complications include oronasal fistula (2 patients),
chronic otitis media (2 patients), and nasopharyngeal stenosis (1 patient).
Conclusion Although poor wound healing is evident, the overall 5-year survival
of 83% is encouraging.
INTRODUCTION
THE LOCAL control rate of nasopharyngeal carcinoma treated with external
beam radiation (EBRT) has ranged between 18% and 54%.1-4 Preliminary
optimistic results have been reported with the use of stereotactic radiosurgery
or intensity-modulated radiation therapy, with and without chemotherapy.5 Pending extended follow-up, the effectiveness of multimodality
therapy in controlling local disease is yet to be defined.
Even more trying is locally recurrent or persistent local disease in
patients who have received 2 courses of EBRT. Hwang et al6 found
that 38 (51%) of their 74 patients retreated with EBRT had persistent disease
after the second course. The surgical excision of nasopharyngeal carcinoma
in reirradiated patients is rarely attempted; hence, the role of surgery in
this population remains poorly defined.
METHODS
In a retrospective review of salvage nasopharyngectomy performed at
Stanford University Medical Center, we report the outcome in 6 of 44 patients
who underwent resection of recurrent nasopharyngeal carcinoma after receiving
2 courses of EBRT. The remaining 38 patients underwent surgical resection
after a single course of EBRT had failed, and results were reported in previous
reviews.7-8 This group of 6 patients
is composed of 4 women and 2 men aged between 35 and 67 years. All patients
underwent 2 courses of EBRT with a mean total dose of 11 500 rad (115
Gy) (range, 9500-13 200 rad [95-132 Gy]) delivered to the nasopharynx.
In addition, 2 patients received intracavitary seeds. The mean duration between
the second course of radiation therapy and surgical resection is 21 months
(range, 8-52 months). The goal of surgical treatment in all 6 patients was
curative resection.
Patient selection was based on the extent of local disease. Resection
was offered to surgical candidates who showed no evidence of new onset cranial
nerve involvement or intracranial extension. Given the difficulty of distinguishing
bony involvement from osteoradionecrosis after high-dose EBRT, bony erosion
seen on imaging was not a contraindication to the procedure.
The surgical technique is based on the work of Wilson9 with
the modifications outlined by Fee et al7 in
1988. All patients underwent a transpalatal approach as well as transcervical
approach (for carotid artery isolation). This was supplemented with a transantral
approach in 1 patient and facial degloving in another. The clivus (and first
vertebral body) was drilled with a large cutting burr, and a wide sphenoidotomy
was created. The defect was covered using a split-thickness skin graft. All
patients received perioperative antibiotics as long as the nasal packing remained
in place.
RESULTS
All patients tolerated the surgical resection without immediate complications
and had a mean hospital stay of 5 days (range, 1-11 days). Patient 2 was kept
intubated overnight. Patient 1 had temporary dysphagia that resolved prior
to discharge. Three patients tolerated an oral diet at the time of discharge,
and 2 patients were discharged on nasogastric tube feeds (which were discontinued
during follow-up outpatient visit). No diet information is available for patient
4.
The most common complication is osteomyelitis of the clival bone, which
was seen in 5 patients. Poor skin graft adherence was seen in all 5 patients.
All patients were treated with oral antibiotics (culture directed, if possible),
and 3 required home intravenous antibiotics. Three patients underwent operative
debridement and replacement of split-thickness skin graft with excellent results.
Other complications included oronasal fistula, which developed in 2
patients and required surgical closure in 1. Patient 3 developed a nasopharyngeal
stenosis that was released during debridement of the nasopharynx. Two patients
developed chronic otitis media.
The mean follow-up period is 7.2 years (range, 4.2-11.5 years). Five
years after resection, patient 4 died of disease. The remaining 5 patients
(83%) are alive with no evidence of disease.
COMMENT
After 2 courses of EBRT, little is left in the way of curative treatment
of persistent or recurrent nasopharyngeal carcinoma. Given that few such patients
undergo surgical resection, the role of nasopharyngectomy in this group remains
poorly defined. In a 1997 retrospective analysis, Hsu et al4 included
7 of their patients who underwent nasopharyngectomy after 2 or more courses
of radiation therapy. Their patients received a mean of 12 800 rad (128
Gy) of EBRT preoperatively and had a mean follow-up of 19 months after nasopharyngectomy.
Only 1 patient was alive without evidence of disease, 1 was alive with local
disease, 1 died from distant metastasis, 3 died from local disease, and 1
died from another cause (cerebrovascular accident). Osteomyelitis was seen
in only 1 of the 7 patients, 1 patient had cranial nerve X and XII palsy,
and another had an oronasal fistula.
The morbidity of nasopharyngectomy in twice-irradiated patients is dominated
by poor wound healing. None of our patients had a cerebrospinal fluid leak,
meningitis, or perioperative death. Osteomyelitis was seen in most (83%) of
our patients secondary to poor bone coverage using the split-thickness skin
graft. There is a need for more durable reconstructive techniques. Although
free-flap reconstruction would provide healthy tissue for bone coverage, anchoring
the flap in this location poses a challenge. Oronasal fistula was seen in
2 patients (33%). In comparison, Fee et al8 reported
a series of 15 patients who underwent nasopharyngectomy after only 1 course
of radiation therapy. The complications reported include 2 patients (13%)
with permanent cranial nerve paralysis, 2 (13%) with osteomyelitis requiring
intravenous antibiotics, 2 (13%) with aspiration pneumonia, 2 (13%) requiring
prolonged nasogastric tube feedings, and 1 (7%) with intraoperative thyroid
storm. Although both series included very small numbers of patients, a comparison
suggests that twice-irradiated patients are at a higher risk of poor wound
healing.
As for outcome, the high rate of patients (83%) alive without disease
suggests the potential effectiveness of the procedure in twice-irradiated
patients. A larger prospective series can best assess the role of surgery
in this group.
CONCLUSIONS
Given the small number of patients studied in our series, we hesitate
to make definitive conclusions on the effectiveness of nasopharyngectomy in
twice-irradiated patients. However, the results of this review suggest that
in appropriately selected patients, the second course of radiation therapy
does not contraindicate surgical resection, and, in fact, the long-term outcome
can be excellent. In our patient population, it increased the morbidity of
the procedure. Poor wound healing should be anticipated, and great emphasis
should be placed on the reconstruction of the surgical bed, including the
use of a forearm free flap.
AUTHOR INFORMATION
Accepted for publication April 8, 2002.
The study was presented at the Fifth International Conference on Head
and Neck Cancer, San Francisco, Calif, July 30, 2001.
Corresponding author and reprints: Hani Z. Ibrahim, MD, 30 N Michigan
Ave, Suite 1107, Chicago, IL 60602 (e-mail: ibrahimhani{at}hotmail.com).
From the Department of Otolaryngology & Bronchoesophagology, Rush-Presbyterian-Saint
Luke's Medical Center, Chicago, Ill (Dr Ibrahim); and the Division of OtolaryngologyHead
& Neck Surgery, Stanford University Medical Center, Stanford, Calif (Drs
Moir and Fee).
REFERENCES
 |  |
1. Sham JT, Choy D. Prognostic factors of nasopharyngeal carcinoma: a review of 759 patients. Br J Radiol. 1990;63:51-58.
FREE FULL TEXT
2. Lee AW, Law SC, Foo W, et al. Retrospective analysis of patients with nasopharyngeal carcinoma treated
during 1976-1985: survival after local recurrence. Int J Radiat Oncol Biol Phys. 1993;26:773-782.
WEB OF SCIENCE
| PUBMED
3. Yamashita S, Konda M, Hashinoto S. Squamous cell carcinoma of the nasopharynx: an analysis of failure
patterns after radiation therapy. Acta Radiol Oncol. 1985;24:315-320.
WEB OF SCIENCE
| PUBMED
4. Hsu MM, Ko JY, Sheen TS, et al. Salvage surgery for recurrent nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg. 1997;123:305-309.
FREE FULL TEXT
5. Tate DJ, Adler JR Jr, Chang SD, et al. Stereotactic radiosurgical boost following radiotherapy in primary
nasopharyngeal carcinoma: impact on local control. Int J Radiat Oncol Biol Phys. 1999;45:915-921.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
6. Hwang JM, Fu KK, Phillips TL. Results and prognostic factors in the retreatment of locally recurrent
nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 1998;41:1109-1111.
7. Fee WE, Gilmer PA, Goffinet DR. Surgical management of recurrent nasopharyngeal carcinoma after radiation
failure at the primary site. Laryngoscope. 1988;98:1220-1226.
WEB OF SCIENCE
| PUBMED
8. Fee WE, Roberson JB Jr, Goffinet DR. Long-term survival after surgical resection for recurrent nasopharyngeal
cancer after radiotherapy failure. Arch Otolaryngol Head Neck Surg. 1991;117:1233-1236.
FREE FULL TEXT
9. Wilson CP. Observations on the surgery of the nasopharynx. Ann Otol Rhinol Laryngol. 1957;66:5-40.
PUBMED
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|